Creative Bioarray Releases Immortalized Cell Lines to Support Generating Accurate Biological Data

Jun 6, 2023

New York City, New York Jun 6, 2023 (Issuewire.com) - Creative Bioarray, one of the top leading biotechnology products and services providers, is committed to providing complete and authentic cell products and services for worldwide clients. Creative Bioarray proudly develops innovative technologies for the cell biology, pharmaceutical, biotechnology, and specialty ingredients markets and is dedicated to supplying the best products and services with global manufacturing, development expertise, and advanced technologies to enhance the overall quality of life. Recently, Creative Bioarray announced the release of its immortalized cell lines to support generating accurate biological data and support further research.

Immortalized cells are derived from primary cells: introduce exogenous immortalized genes (recombinant lentivirus, retrovirus & adenovirus EBV, HPV E6/7 and SV40 T antigens, hTERT, p53) into target cells by gene transfection technology, to establish immortalized cell lines, to achieve in vitro cell culture, so that the cells cultured in vitro have the ability to proliferate, and there is no difference between cells. Through immortalization, cells that are difficult to pass on, slow to proliferate, and prone to aging can be immortalized, thereby providing researchers with more cell resources and providing good in vitro cell model for scientific research. Creative Bioarray has about 60 immortalized cell lines, including human immortalized cells, mouse immortalized cells and rat immortalized cells, and also provides customized cell immortalization services for customers' unique solutions.

Creative Bioarray's experts have more than 10 years of experience in cell immortalization and have developed a variety of cell immortalization products. One of the featured products is the hTERT-induced immortality service, which offers, in addition to plasmids, retroviral, lentiviral and adenoviral vectors, p53 and RB, siRNA and SV40 T antigen. Meanwhile, Creative Bioarray also provides ready-to-use recombinant retroviruses, lentiviruses, and adenoviruses incorporating these genes.

In addition, Creative Bioarray provides the latest methods for cell immortalization, as well as specific guidelines for immortalizing kidney and thyroid epithelial cells, hepatocytes, fibroblasts, chondrocytes, lymphocytes, astrocytes, and human umbilical vein endothelial cells.

"Creative Bioarray is committed to providing the latest in vitro methods and safety procedures for the immortalization of various cell types. We have the ability to meet your needs and achieve the desired goals of your research." said Hannah Cole, the marketing director of Creative Bioarray, she also claimed, "Our team devotes to helping our customers accelerate life sciences research, solve complex analytical challenges and increase laboratory productivity."

About Creative Bioarray

Creative Bioarray is dedicated to offering customers innovative biotechnology products and services for research use to greatly enhance and drive innovation and standards in science. As a well-recognized industry leader with more than 10 years of experience and in-house expert support, Creative Bioarray has already countenanced research all around the world.

Media Contact

Creative Bioarray


[email protected]

1 631 386 8241

Shirley, NY 11967, USA

https://www.creative-bioarray.com/

Source :Creative Bioarray

This article was originally published by IssueWire. Read the original article here.

More News

Paul George and Jayson Tatum lead Celtics to a 117-97 victory over the Bucks
Nov 9, 2026

Paul George and Jayson Tatum lead Celtics to a 117-97 victory over the Bucks

MILWAUKEE — Paul George scored 27 points, Jayson Tatum added 21 and the Boston Celtics rolled to a 117-97 victory over the slumping Milwaukee Bucks on Sunday night. This marked the second matchup between these teams in five nights. The Celtics had beaten the Bucks 109-102 on Wednesday in Boston while resting Tatum. Boston (8-2) built a big enough lead Sunday to sit Tatum for the entire fourth quarter as the Celtics continued a four-game trip that started with a 119-80 win at Charlotte on Friday. The Celtics next head to Philadelphia and Toronto. Kyle Kuzma led Milwaukee with 27 points. Myles Turner scored just three points for the Bucks, though he did have five rebounds and a career-high seven assists. Turner, who has shot 1 of 15 over his last two games, was coming off a scoreless performance in a 121-107 NBA Cup loss to the Toronto Raptors on Frieday. The Bucks (1-9) are off to their worst start since 1993-94, when they lost 10 of their first 11 games and went on to finish 20-62. Kuzma scored 14 points in the first five minutes of the game to help Milwaukee grab an early 20-6 lead. Tatum and George sparked an 18-0 run that enabled the Celtics to take control later in the first half. Tatum scored the final 10 points of the first quarter to cut Milwaukee’s lead to 27-25. George delivered the first eight points of the second period. George’s 3-pointer in the opening minute of the second quarter gave Boston its first lead at 28-27. George then hit a layup and another 3-pointer to cap the 18-0 spurt. Boston owned a 58-45 halftime advantage. The Celtics scored the first nine points of the third period to extend their lead to 22, and they stayed in front by at least 15 the rest of the way.

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.